Are basal core-IgM antibodies to hepatitis C virus predictive of successful alpha-interferon therapy?
Pawlotsky
J M
JM
Roudot-Thoraval
F
F
Bastie
A
A
Duval
J
J
Dhumeaux
D
D
D000328:Adult; D000368:Aged; D005260:Female; D006526:Hepatitis C / Q000276:immunology / Q000628:therapy*; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood*; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D014758:Viral Core Proteins / Q000276:immunology*
D018937:Hepatitis C Antibodies; D007075:Immunoglobulin M; D016898:Interferon-alpha; D014758:Viral Core Proteins